R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
- Status
- COMPLETED
- Phase
- PHASE2
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402
- Status
- COMPLETED
- Phase
- N/A
Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
- Status
- COMPLETED
- Phase
- N/A
The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
- Status
- COMPLETED
- Phase
- N/A
Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
- Status
- COMPLETED
- Phase
- N/A
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma
- Status
- COMPLETED
- Phase
- N/A